Exact Mass: 340.0269104
Exact Mass Matches: 340.0269104
Found 27 metabolites which its exact mass value is equals to given mass value 340.0269104
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
2-(6-bromoquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone
Methyl (2R)-2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate
2-ETHOXY-5-(PYRIDINE-2-CABOXAMIDO) BENZENE-1-SULFONYL CHLORIDE
2-(7-bromoquinolin-4-yl)-1-(6-methylpyridin-2-yl)ethanone
Minodronic acid monohydrate
D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
Fenoprofen CalciuM Salt Dihydrate
C15H14O3.1/2Ca.H2O (340.0300356)
Methyl (2S)-2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate
2-ETHOXY-5-[(PYRIDINE-3-CARBONYL)-AMINO]-BENZENESULFONYL CHLORIDE
S-(Trifluoromethyl)dibenzothiophenium tetrafluoroborate
7-Chloro-3-hydroxy-2-[3-(trifluoromethyl)phenyl]-4-quinazolinone
C15H8ClF3N2O2 (340.02263739999995)
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(5-hydroxy-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
C9H13N2O10P (340.03078080000006)
1-(5-Phospho-beta-d-ribofuranosyl)barbituric acid
C9H13N2O10P (340.03078080000006)
[(2S,3R,4R,5R)-3,4-dihydroxy-5-(6-hydroxy-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
C9H13N2O10P (340.03078080000006)
(3S,4S,5S,6S)-6-fluoro-4-hydroxy-3-[hydroxy(methyl)phosphoryl]oxy-5-(2-hydroxyprop-2-enoyloxy)cyclohexene-1-carboxylic acid
C11H14FO9P (340.03594560000005)
(3S,4S,5S,6R)-6-fluoro-4-hydroxy-3-[hydroxy(methyl)phosphoryl]oxy-5-(2-hydroxyprop-2-enoyloxy)cyclohexene-1-carboxylic acid
C11H14FO9P (340.03594560000005)
[(2S,3R,4R,5R)-3,4-dihydroxy-5-(2,4,6-trioxo-1,3-diazinan-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
C9H13N2O10P (340.03078080000006)
5,6-Dihydroxy-2-deoxyuridine 5-monophosphate
C9H13N2O10P (340.03078080000006)
A pyrimidine 2-deoxyribonucleoside 5-monophosphate having 5,6-dihydroxyuracil as the nucleobase.
SBI-115
SBI-115 is a TGR5 (GPCR19) antagonist. SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5[1].